• To be able to describe the epidemiology, aetiology and risk factors of endometrial cancer

  • To be able to perform specialist assessment and to develop a multidisciplinary management plan for newly diagnosed patients with endometrial cancer

  • To be able to formulate treatment plans for patients with recurrent endometrial cancer, including palliation

  • Awareness of risk factors

  • Awareness of symptoms and signs

  • Appreciation of the evidence and indications for screening, prevention and surveillance measures

  • Awareness of imaging modalities to diagnose and manage endometrial cancer

  • Appreciation of fertility preservation options

  • Awareness of survivorship-related issues

  • Recognition of genetic predisposition to endometrial cancer, eg, Lynch syndrome

  • Awareness of molecular alterations in endometrial cancer

  • Knowledge of the staging systems used in endometrial cancer

  • Familiarity with the histological subtypes of endometrial cancer (including carcinosarcoma) and the associated clinical behaviour

  • Familiarity with defining the risk stratification of endometrial cancer (low, intermediate and high risk)

  • Understanding of the management of newly diagnosed endometrial cancer in relation to stage and risk groups:

    • Indications for surgery (including minimally invasive techniques, role of lymphadenectomy) and radiotherapy

    • Indications for adjuvant systemic therapy

  • Understanding of the management of recurrent endometrial cancer:

    • Systemic treatment options (role for chemotherapy and hormonal therapy)

    • Role for surgery in relapsed disease, including palliative procedures

    • Role for palliative radiotherapy

  • Ability to contribute to the multidisciplinary management decisions of patients with newly diagnosed and recurrent endometrial cancer

  • Ability to evaluate patients for therapy (history and physical examination, including internal) and to discuss prognosis and treatment options

  • Ability to determine management plans for newly diagnosed patients with endometrial cancer according to stage and risk stratification, taking into consideration comorbidities and performance status

  • Ability to determine and prescribe systemic therapy plans for patients with recurrent endometrial cancer, taking into consideration performance status, comorbidities and prior toxicities

  • Ability to assess and manage disease-related events (eg, vaginal bleeding), complications of radiotherapy and systemic therapy

  • Ability to discuss cancer follow-up with patients